Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform

NCT ID: NCT06483295

Last Updated: 2025-05-28

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 216 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-03-24
• Study Completion Date: 2026-12-31

Brief Summary

This study focuses on the significant impact of lung cancer in China, highlighted by its high incidence and mortality rates, influenced by factors like aging populations, smoking, and environmental issues. It emphasizes the importance of understanding the duration, severity, and factors affecting post-surgery symptoms like pain and coughing in patients. The research underlines the value of patient-reported outcomes (PROs) in enhancing postoperative care and survival rates through improved symptom monitoring and patient engagement. Utilizing internet technology, specifically a platform integrated with WeChat, the study aims to improve patient management and follow-ups post-discharge. The objective is to use mobile internet technology to build a high-quality prospective database on postoperative lung cancer patient outcomes, analyzing factors affecting postoperative discomfort and assessing the role of interactive platforms in improving patient care.

Detailed Description

Lung cancer is the leading cause of cancer-related deaths worldwide. In China, it has become the malignancy with the highest incidence and mortality rates, exacerbated by aging populations, smoking, and environmental issues. Post-major lung surgery, patients often experience reduced quality of life due to symptoms like pain and coughing. However, the duration, severity, and factors influencing these symptoms during recovery are not fully understood. Notably, recent attention has been given to the direct collection of patient-reported outcomes (PROs) for subjective symptom monitoring and improving patient care. Incorporating PRO monitoring in cancer patient follow-ups can reduce postoperative discomfort, enhance treatment tolerance and adherence, detect early relapses, and improve survival rates. Internet technology significantly expands information exchange frequency and efficiency. Management platforms based on internet mobile applications can enhance patient management compliance, enable intelligent follow-ups, and strengthen doctor-patient interaction. The investigators' hospital intends to utilize its internet hospital platform, integrated with WeChat (a Tencent application in China), for assisting in-patient management and post-discharge surveillance through automated multimedia material and PROs. WeChat, similar to Facebook and WhatsApp, is a multifunctional messenger app with over a billion active monthly users in China, effectively using an application already familiar to patients rather than introducing new ones.

This study aims to leverage mobile internet technology to transform traditional database construction, enhance the efficiency and accuracy of prospective database information collection, and establish a high-quality prospective database of postoperative lung cancer patient-reported outcomes. This will facilitate the analysis of factors influencing postoperative discomfort in patients and explore the role of interactive mobile internet technology platforms in improving postoperative PROs, thereby elevating the diagnostic and treatment standards in this field.

Conditions

Lung Cancer

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: NONE

Study Groups

Group A

Mobile Internet Platform Follow-up Group

Group Type: EXPERIMENTAL

Using mobile internet platforms for follow-up management of postoperative symptoms in lung cancer patients.

Intervention Type: OTHER

Using mobile internet platforms for follow-up management of postoperative symptoms in lung cancer patients.

Group B

Traditional Outpatient Follow-up Group

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

Using mobile internet platforms for follow-up management of postoperative symptoms in lung cancer patients.

Using mobile internet platforms for follow-up management of postoperative symptoms in lung cancer patients.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

1. Diagnosed with Stage I-III lung cancer and surgically resected at our centre.

2. Owns and uses a smartphone and can use WeChat.

3. Volunteer to participate in this study and sign an informed consent form.

Exclusion Criteria

1. Received any non-surgical anti-tumour therapy (radiotherapy, chemotherapy, targeted therapy or immunotherapy) for lung cancer during the follow-up period.

2. After enrolment, preoperative emergence of serious comorbidities (inability to tolerate surgery or anaesthesia) that are not suitable for, or cannot be implemented as planned, in the study's treatment regimen.

3. After admission, the patient's condition changes and the need to change from elective surgery to emergency surgery is confirmed by the doctor in charge.

4. At any stage after entering the study, the patient voluntarily requests to withdraw or discontinue treatment due to personal reasons.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Shanghai Chest Hospital

OTHER

Sponsor Role: lead

Responsible Party

Xinghua Cheng

Director, Head of Oncology Surgery, Clinical Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Xinghua Cheng, MD

Role: PRINCIPAL_INVESTIGATOR

Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Locations

Zuodong Song

Shanghai, Shanghai Municipality, China

Site Status: RECRUITING

Countries

China

Central Contacts

Xinghua Cheng, MD

Role: CONTACT

chengxinghua_001@163.com

+8617701681215

Xinghua Cheng

Role: CONTACT

chengxinghua_001@163.com

+8617701681215

Facility Contacts

Zuodong Song

Role: primary

szd1990@hotmail.com

Other Identifiers

ShanghaiChestPRO

Identifier Type: -

Identifier Source: org_study_id